pentobarbital decreases effects of hemin by pharmacodynamic antagonism. Use Warning/Monitor. Drugs that increase delta-aminolevulinic acid synthetase may reduce hemin effect.

Problems over the effectiveness of multi-drug lethal injections also encouraged states to show to pentobarbital, Based on specialists.

pentobarbital will lessen the extent or effect of finasteride by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.

Contraindicated (one)pentobarbital will lower the level or effect of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the extent or effect of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will lessen the level or effect of ondansetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. No dosage adjustment for ondansetron is usually recommended for patients on these drugs.

pentobarbital will decrease the level or effect of isradipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.

pentobarbital will lower the level or effect of flurbiprofen by affecting hepatic enzyme CYP2C9/10 metabolism. Minimal/Significance Unidentified.

pentobarbital will decrease the extent or effect of voriconazole by impacting hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Unfamiliar.

pentobarbital will minimize the extent or effect of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the extent or effect of irinotecan by affecting hepatic/intestinal here enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will lower the extent or effect of dasatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will reduce the level or effect of tolterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

Acute or Long-term ache: Warning must be exercised when barbiturates are administered to patients with acute or Long-term discomfort, due to the fact paradoxical excitement may very well be induced or essential symptoms can be masked.